Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mesna side effects which imitate vasculitis.

E Reinhold-Keller1, J Mohr, E Christophers

  • 1Abteilung klinische Rheumatologie, Medizinischen Universität zu Lübeck.

The Clinical Investigator
|August 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Diagnosis and treatment of ANCA-associated vasculitis : S3 guideline of the German Society for Rheumatology and Clinical Immunology e. V. (DGRh) and German Society for Internal Medicine e. V. (DGIM), German Society for Nephrology e. V. (DGfN), German Society for ENT Medicine and Head and Neck Surgery e. V. (DGHNO-KHC), German Ophthalmological Society e. V. (DOG), German Society for Neurology e. V. (DGN), German Society for Pneumology and Respiratory Medicine e. V. (DGP), German Society for Pathology e. V. (DGP), German Radiological Society, Society for Medical Radiology e. V. (DRG), Federal Association of German Pathologists, Federal Kidney Association e. V., German Rheumatism League Federal Association e. V.]

Zeitschrift fur Rheumatologie·2025
Same author

[Diagnosis and treatment of ANCA-associated vasculitis : SHORT VERSION of the S3 guideline of the German Society for Rheumatology and Clinical Immunology e. V. (DGRh) and German Society for Internal Medicine e. V. (DGIM), German Society for Nephrology e. V. (DGfN), German Society for Otorhinolaryngology and Head and Neck Surgery e. V. (DGHNO-KHC), German Ophthalmological Society e. V. (DOG), German Society for Neurology e. V. (DGN), German Society for Pneumology and Respiratory Medicine e. V. (DGP), German Society for Pathology e. V. (DGP), German Radiological Society, Society for Medical Radiology e. V. (DRG), Federal Association of German Pathologists, Federal Kidney Association e. V., German Rheumatism League Federal Association e. V.]

Zeitschrift fur Rheumatologie·2025
Same author

Pustular diseases and keratinocyte-myeloid synergy.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Severity, heterogeneity and systemic inflammation in psoriasis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same author

Pioneers in dermatology and venereology: an interview with Prof. Enno Christophers.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same author

[Vasculitis mimics].

Zeitschrift fur Rheumatologie·2019

Mesna (sodium-2-mercaptoethansulfonate) can cause severe hypersensitivity reactions, including skin and cardiac issues, in patients treated with cyclophosphamide (CYC). This study highlights the potential for Mesna to induce delayed hypersensitivity, necessitating careful patient monitoring.

Area of Science:

  • Pharmacology
  • Toxicology
  • Immunology

Background:

  • Mesna (sodium-2-mercaptoethansulfonate) is a standard prophylactic agent against cyclophosphamide (CYC)-induced hemorrhagic cystitis.
  • Cyclophosphamide is an alkylating agent used in treating various autoimmune diseases and cancers.

Observation:

  • Four patients receiving low-dose CYC and prednisone for vasculitis developed severe adverse events approximately three weeks after initiating Mesna therapy.
  • Symptoms included fever, arthralgia, myalgia, tachycardia, electrocardiogram changes indicative of perimyocarditis, erythroderma, and bullous lesions on skin and mucous membranes.

Findings:

  • Positive re-exposure tests confirmed Mesna as the causative agent for the observed severe side effects.
  • Hypersensitivity skin tests revealed a delayed hypersensitivity reaction to Mesna.

Related Experiment Videos

Implications:

  • This case series suggests that Mesna can induce severe, delayed hypersensitivity reactions, extending beyond typical urinary tract protection.
  • Clinicians should be vigilant for systemic hypersensitivity reactions to Mesna, particularly in patients with autoimmune conditions on long-term therapy.
  • Further investigation into the immunological mechanisms of Mesna hypersensitivity is warranted.